Images in gynecology: A ‘Hemostatoma’ following resection of Endometriosis

Publication date: Available online 22 November 2019Source: Journal of Minimally Invasive GynecologyAuthor(s): Dr Kavita Ravendran, Dr Aaron Budden, Professor Jason Abbott
Source: Journal of Minimally Invasive Gynecology - Category: OBGYN Source Type: research

Related Links:

Publication date: Available online 2 June 2020Source: European Journal of Obstetrics &Gynecology and Reproductive BiologyAuthor(s): Sabine Moehner, Kerstin Becker, Jens A. Lange, Sophia von Stockum, Klaas Heinemann
Source: European Journal of Obstetrics and Gynecology and Reproductive Biology - Category: OBGYN Source Type: research
SPONSORED POST By BAYER G4A Digital health is changing the world From chronic disease management to prevention, G4A’s goal is to empower people with the tools and access they need to take control of their health. G4A does this through fostering a diverse and vibrant ecosystem of digital health partners to support their growth and impact. On April 20th, G4A launched its 2020 Partnership Program with an open call for applications. The aim of the Partnerships Program is to work with companies across the globe on healthcare’s toughest challenges and innovate together towards a future of integrated ...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Health Tech Bayer Bayer G4A Bayer G4A Partnerships Program digital health Source Type: blogs
To study the effect of a new investigational oral gonadotropin-releasing hormone antagonist, linzagolix, on endometriosis-associated pain (EAP).
Source: Fertility and Sterility - Category: Reproduction Medicine Authors: Tags: Original article Source Type: research
Dienogest (DNG) 2  mg (Visanne) was approved for endometriosis treatment in Europe in 2010. The Visanne Post-approval Observational Study (VIPOS) was designed to assess the safety of DNG 2 mg/day compared to other hormonal endometriosis treatments, focusing especially on clinically relevant depression and anemia.
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - Category: OBGYN Authors: Tags: Full length article Source Type: research
ConclusionsAlthough no human studies have been performed so far, the cell and animal model study results suggest that LXA4 will be used in obstetrics and gynecology soon.
Source: Inflammation Research - Category: Research Source Type: research
Condition:   Endometriosis, Rectum Interventions:   Diagnostic Test: Transvaginal ultrasound;   Behavioral: 5-point Likert scale Sponsor:   Ospedale Policlinico San Martino Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Publication date: Available online 14 May 2020Source: Reproductive BioMedicine OnlineAuthor(s): Jessica Ottolina, Matteo Schimberni, Sofia Makieva, Ludovica Bartiromo, Teresa Fazia, Luisa Bernardinelli, Paola Viganò, Massimo Candiani, Davide Gentilini
Source: Reproductive BioMedicine Online - Category: Reproduction Medicine Source Type: research
Publication date: Available online 21 May 2020Source: European Journal of Obstetrics &Gynecology and Reproductive BiologyAuthor(s): Tomasz Szaflik, Beata Smolarz, Hanna Romanowicz, Magdalena Bryś, Ewa Forma, Krzysztof Szyłło
Source: European Journal of Obstetrics and Gynecology and Reproductive Biology - Category: OBGYN Source Type: research
Publication date: Available online 31 May 2020Source: PhytomedicineAuthor(s): Yi-Wen Hsu, Hsin-Yuan Chen, Yi-Fen Chiang, Li-Chun Chang, Po-Han Lin, Shih-Min Hsia
Source: Phytomedicine - Category: Drugs & Pharmacology Source Type: research
To evaluate the rate of postoperative complications between conservative surgery and segmental resection in patients with rectal endometriosis.
Source: Fertility and Sterility - Category: Reproduction Medicine Authors: Tags: Original article Source Type: research
More News: Endometriosis | OBGYN